Moderna opens UK vaccine manufacturing lab

Covid vaccine manufacturer Moderna has completed a new site in the UK, which it says will help prepare the the country against future pandemics.
The Moderna Innovation and Technology Centre (MITC) in Harwell, Oxfordshire, is now fully operational and has its manufacturer's license by the Medicines and Healthcare products Regulatory Agency.
Moderna's UK general manager Darius Hughes calls it an "an important pillar of our pandemic preparedness".
US company Moderna became a household name during the Covid pandemic, creating successful vaccines using a new technology called mRNA.
It used genetic code to create an immune response by giving the body the instructions to protect against the virus.
It proved to be one of the fastest routes to developing vaccines during the pandemic, and experts believe the technology could help in other areas such as cancer, flu, and heart disease.
Mr Hughes describes the new set up as an "onshore supply chain manufacturing process" that will "really enable us to scale up within 100 days to make British vaccines for the UK public".
He adds: "We are working very closely with the UK Health Security Agency (UKHSA) and with other government agencies to make sure we are learning from the previous pandemic, and applying those learnings, and getting ourselves a little bit better prepared should another pandemic be declared."
One of the key features of the facility is speed. It is set up to react quickly so manufacturing can change from one vaccine to another as the country needs it.
Mr Hughes says: "One week we could be making a couple of million Covid vaccines, the next week we could be making a couple of million norovirus vaccines. It's that level of flexibility.
"And even within a season, if the virus might change or mutate... we could get a new code, a new set of messages, and make a new vaccine within weeks."
Aside from vaccine production, labs will also process samples from clinical trials working on the development of new drugs, and scientists have already starting looking at the effectiveness of new protections against norovirus.
Previously a government-funded facility, known as the Vaccine Manufacturing and Innovation Centre (VMIC), was based in Harwell.
It ended up being sold to pharmaceutical company Catalent in 2022 before it was finished.
The VMIC had been set up as a not-for-profit company with the aim of combining vaccine research and manufacturing in one place.
The establishment of the MITC is part of a ten-year strategic partnership between Moderna and the government, managed by the UKHSA.
The government will buy the vaccines made here as part of the deal.
The first priority is a new covid vaccine for the NHS for next winter.
You can follow BBC Oxfordshire on Facebook, X (Twitter), or Instagram.
Science park chosen for new Moderna vaccine base
New vaccine centre sold to company
Moderna United Kingdom
Medicines and Healthcare products Regulatory Agency

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Chicago Tribune

an hour ago

• Chicago Tribune

US measles count now tops 1,200 cases, and Iowa announces an outbreak

The U.S. logged fewer than 20 measles cases this week, though Iowa announced the state's first outbreak Thursday and Georgia confirmed its second Wednesday. There have been 1,214 confirmed measles cases this year, the Centers for Disease Control and Prevention said Friday. Health officials in Texas, where the nation's biggest outbreak raged during the late winter and spring, confirmed six cases in the last week. There are three other major outbreaks in North America. The longest, in Ontario, Canada, has resulted in 2,179 cases from mid-October through June 17. The province logged its first death June 5 in a baby who got congenital measles but also had other preexisting conditions. Another outbreak in Alberta, Canada, has sickened 996 as of Thursday. And the Mexican state of Chihuahua had 2,335 measles cases and four deaths as of Friday, according to data from the state health ministry. Other U.S. states with active outbreaks — which the CDC defines as three or more related cases — include Arizona, Colorado, Illinois, Kansas, Montana, New Mexico, North Dakota and Oklahoma. In the U.S., two elementary school-aged children in the epicenter in West Texas and an adult in New Mexico have died of measles this year. All were unvaccinated. Measles vaccination rates drop after COVID-19 pandemic in counties across the USMeasles is caused by a highly contagious virus that's airborne and spreads easily when an infected person breathes, sneezes or coughs. It is preventable through vaccines and has been considered eliminated from the U.S. since 2000. There are a total of 750 cases across 35 counties, most of them in West Texas, state health officials said Tuesday. Throughout the outbreak, 97 people have been hospitalized. State health officials estimated less than 1% of cases — fewer than 10 — are actively infectious. Fifty-five percent of Texas' cases are in Gaines County, where the virus started spreading in a close-knit, undervaccinated Mennonite community. The county has had 413 cases since late January — just under 2% of its residents. The April 3 death in Texas was an 8-year-old child, according to Health Secretary Robert F. Kennedy Jr. Local health officials said the child did not have underlying health conditions and died of 'what the child's doctor described as measles pulmonary failure.' A unvaccinated child with no underlying conditions died of measles in Texas in late February; Kennedy said the child was 6. New Mexico held steady Friday with a total of 81 cases. Seven people have been hospitalized since the outbreak started. Most of the state's cases are in Lea County. Sandoval County near Albuquerque has six cases, Eddy County has three, Doña Ana County has two. Chaves, Curry and San Juan counties have one each. An unvaccinated adult died of measles-related illness March 6. The person did not seek medical care. Oklahoma added one case Friday for a total of 17 confirmed and three probable cases. The state health department is not releasing which counties have cases. Arizona has four cases in Navajo County. They are linked to a single source, the county health department said June 9. All four were unvaccinated and had a history of recent international travel. Colorado has seen a total of 16 measles cases in 2025, which includes one outbreak of 10 related cases. The outbreak is linked to a Turkish Airlines flight that landed at Denver International Airport in mid-May. Four of the people were on the flight with the first case — an out-of-state traveler not included in the state count — while five got measles from exposure in the airport and one elsewhere. Health officials are also tracking an unrelated case in a Boulder County resident. The person was fully vaccinated but had 'recently traveled to Europe, where there are a large number of measles cases,' the state health department said. Other counties that have seen measles this year include Archuleta and Pueblo. Georgia has an outbreak of three cases in metro Atlanta, with the most recent infection confirmed Wednesday. The state has confirmed six total cases in 2025. The remaining three are part of an unrelated outbreak from January. Illinois health officials confirmed a four-case outbreak on May 5 in the far southern part of the state. It grew to eight cases as of June 6, but no new cases were reported in the following weeks, according to the Illinois Department of Public Health. The state's other two cases so far this year were in Cook County, and are unrelated to the southern Illinois outbreak. Illinois unveils online tool showing measles vaccination rates by schoolIowa has had six total measles cases in 2025. Four are part of an outbreak in eastern Johnson County, among members of the same household. County health officials said the people are isolating at home, so they don't expect additional spread. Kansas has a total of 79 cases across 11 counties in the southwestern part of the state, with three hospitalizations. All but three of the cases are connected, and most are in Gray County. Montana had 22 measles cases as of Friday. Fourteen were in Gallatin County, which is where the first cases showed up — Montana's first in 35 years. Flathead and Yellowstone counties had two cases each, and Hill County had four cases. There are outbreaks in neighboring North Dakota and the Canadian provinces of Alberta, British Columbia and Saskatchewan. North Dakota, which hadn't seen measles since 2011, was up to 34 cases as of June 6, but has held steady since. Two of the people have been hospitalized. All of the people with confirmed cases were not vaccinated. There were 16 cases in Williams County in western North Dakota on the Montana border. On the eastern side of the state, there were 10 cases in Grand Forks County and seven cases in Cass County. Burke County, in northwest North Dakota on the border of Saskatchewan, Canada, had one case. Measles cases also have been reported this year in Alaska, Arkansas, California, District of Columbia, Florida, Hawaii, Indiana, Kentucky, Louisiana, Maryland, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, Rhode Island, South Dakota, Vermont, Virginia and Washington. Health officials declared earlier outbreaks in Indiana, Michigan, Ohio and Pennsylvania over after six weeks of no new cases. Tennessee's outbreak also appears to be over. Cases and outbreaks in the U.S. are frequently traced to someone who caught the disease abroad. The CDC said in May that more than twice as many measles have come from outside of the U.S. compared to May of last year. Most of those are in unvaccinated Americans returning home. In 2019, the U.S. saw 1,274 cases and almost lost its status of having eliminated measles. The best way to avoid measles is to get the measles, mumps and rubella vaccine. The first shot is recommended for children between 12 and 15 months old and the second between 4 and 6 years old. Getting another MMR shot as an adult is harmless if there are concerns about waning immunity, the CDC says. People who have documentation of receiving a live measles vaccine in the 1960s don't need to be revaccinated, but people who were immunized before 1968 with an ineffective vaccine made from 'killed' virus should be revaccinated with at least one dose, the agency said. People who have documentation that they had measles are immune and those born before 1957 generally don't need the shots because so many children got measles back then that they have 'presumptive immunity.' Measles has a harder time spreading through communities with high vaccination rates — above 95% — due to 'herd immunity.' But childhood vaccination rates have declined nationwide since the pandemic and more parents are claiming religious or personal conscience waivers to exempt their kids from required shots. Measles first infects the respiratory tract, then spreads throughout the body, causing a high fever, runny nose, cough, red, watery eyes and a rash. The rash generally appears three to five days after the first symptoms, beginning as flat red spots on the face and then spreading downward to the neck, trunk, arms, legs and feet. When the rash appears, the fever may spike over 104 degrees Fahrenheit, according to the CDC. Most kids will recover from measles, but infection can lead to dangerous complications such as pneumonia, blindness, brain swelling and death. There's no specific treatment for measles, so doctors generally try to alleviate symptoms, prevent complications and keep patients comfortable.

Epoch Times

3 hours ago

• Epoch Times

How Women Can Prevent Hair Loss by Nourishing the Liver and Kidneys

Hair health reflects overall physical well-being. Women often experience hair loss due to various causes, including postpartum recovery, menopause, alopecia areata, or scalp issues such as itchiness and dandruff, exacerbated by summer heat. Traditional Chinese medicine (TCM) offers a holistic approach, emphasizing a blend of targeted dietary supplements, meticulous scalp care, and proper hair-washing techniques to reduce hair loss effectively. Dr. Chen Hsin-hung, a TCM practitioner at Hanyitang Chinese Medicine clinics in Taiwan, shared a case of hair loss. A woman in her 20s developed alopecia areata (patchy baldness) after receiving the COVID-19 vaccine, which left her deeply distressed when her hair almost entirely fell out. Through 6 to 8 months of TCM treatment, she regrew dark, vibrant hair. Exploring Hair Loss Causes With TCM From the perspective of TCM, the liver and kidneys are closely related to hair health as they play a vital role in the internal organ-centered energy system.

Yahoo

6 hours ago

• Yahoo

Teradyne (NasdaqGS:TER) Revamps By-Laws to Modernize Shareholder Procedures and Director Elections

On June 20, 2025, Teradyne implemented significant amendments to its By-Laws, adjusting nomination and proposal notice windows and clarifying voting standards. Over the past month, Teradyne's stock price moved 9% amid these changes, potentially reflecting investor confidence in enhanced governance practices. Although the broader market has remained flat, the recent gains by the company could suggest that these internal updates resonated positively with market participants, aligning with an overall upward market trend over the past year. This internal shift may have added weight to Teradyne's modest divergence from the market's flat performance. Buy, Hold or Sell Teradyne? View our complete analysis and fair value estimate and you decide. These 17 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. The recent amendments to Teradyne's by-laws could potentially reinforce investor confidence, aligning with broader market interests in strong governance. Over a longer five-year span, Teradyne's total shareholder return of 7.61% provides context for its performance, despite the stock's short-term fluctuations. This return contrasts with the company's one-year underperformance, as it lagged behind both the overall US market and the semiconductor industry, indicating room for improvement. The governance changes could influence Teradyne's revenue and earnings positively, particularly in the context of its strategic focus on AI, robotics, and automation. These areas are anticipated to boost revenue, though current geopolitical and tariff concerns could pose risks. Analysts forecast an annual revenue growth of 12.3% and a rise in profit margins to 24.7%, indicating a potential upside, even if challenges persist. The recent share price movement following the changes, while reflective of immediate investor sentiment, shows a notable gap against the consensus price target of US$99.83, which represents a 25.8% potential increase from the current US$74.07. This suggests that investors might be weighing the company's long-term strategic initiatives against current uncertainties. Our valuation report unveils the possibility Teradyne's shares may be trading at a discount. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGS:TER. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data